TOFA Boosts GLP-1 Effectiveness
TOFA, short for 5-tetradecyloxy-2-furoic acid, is a compound recently shown to cause weight loss without the muscle loss associated with GLP-1s, at least in mice.
What’s Behind the Problem Drinking Decline?
Research shows a sharp decline in problem drinking in the U.S., but no one is exactly sure why.
This Is Your Brain On Booze
Researchers find a similar source for alcoholism and obesity, which may explain why GLP-1 drugs appear to treat both diseases.
New Research on GLP-1 Drugs and Substance Use Disorders
A massive Swedish study shows GLP-1 drugs significantly reduce hospitalizations for alcohol use disorder and other substance use disorders.
Breaking the Bond Between Cravings and Consumption
A researcher from New Zealand reveals the importance of the lateral septum in breaking the bond between cravings and consumption.
85% Reduction in Substance Use Disorders With GLP-1 Drugs
A new study finds stunning declines in substance use disorders when people with obesity or type 2 diabetes use GLP-1 drugs.